Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H29N3O3S |
| Molecular Weight | 499.624 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(CC1=C(N=C2C=CC=CC2=C1C(=O)N[C@@H](C3CC3)C4=CC=CC=C4)C5=CC=CC=C5)S(C)(=O)=O
InChI
InChIKey=YTXUTYGRBYCUIL-HHHXNRCGSA-N
InChI=1S/C29H29N3O3S/c1-32(36(2,34)35)19-24-26(29(33)31-27(22-17-18-22)20-11-5-3-6-12-20)23-15-9-10-16-25(23)30-28(24)21-13-7-4-8-14-21/h3-16,22,27H,17-19H2,1-2H3,(H,31,33)/t27-/m1/s1
| Molecular Formula | C29H29N3O3S |
| Molecular Weight | 499.624 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. | 2010-02-10 |
|
| New quinoline NK3 receptor antagonists with CNS activity. | 2009-02-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:33:26 GMT 2025
by
admin
on
Mon Mar 31 23:33:26 GMT 2025
|
| Record UNII |
4NVH197M39
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1133706-08-7
Created by
admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
|
PRIMARY | |||
|
44570980
Created by
admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
|
PRIMARY | |||
|
4NVH197M39
Created by
admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
